nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—SLC10A1—Progesterone—uterine cancer	0.409	0.637	CbGbCtD
Liotrix—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.075	0.117	CbGbCtD
Liotrix—CYP2C8—Progesterone—uterine cancer	0.0497	0.0775	CbGbCtD
Liotrix—ABCB1—Progesterone—uterine cancer	0.0336	0.0525	CbGbCtD
Liotrix—ABCB1—Dactinomycin—uterine cancer	0.0267	0.0416	CbGbCtD
Liotrix—CYP2C8—Etoposide—uterine cancer	0.0222	0.0347	CbGbCtD
Liotrix—ABCB1—Etoposide—uterine cancer	0.0151	0.0235	CbGbCtD
Liotrix—ABCB1—Doxorubicin—uterine cancer	0.0103	0.016	CbGbCtD
Liotrix—SLC16A2—myometrium—uterine cancer	0.00287	0.0373	CbGeAlD
Liotrix—SLCO4C1—renal system—uterine cancer	0.00241	0.0313	CbGeAlD
Liotrix—SLCO4C1—endometrium—uterine cancer	0.00233	0.0302	CbGeAlD
Liotrix—THRB—renal system—uterine cancer	0.00231	0.03	CbGeAlD
Liotrix—THRA—renal system—uterine cancer	0.00231	0.03	CbGeAlD
Liotrix—SLCO4C1—mammalian vulva—uterine cancer	0.00225	0.0292	CbGeAlD
Liotrix—SLC16A2—uterine cervix—uterine cancer	0.00224	0.029	CbGeAlD
Liotrix—SLCO4A1—myometrium—uterine cancer	0.00211	0.0274	CbGeAlD
Liotrix—SLC10A1—renal system—uterine cancer	0.00204	0.0265	CbGeAlD
Liotrix—SLC16A2—endometrium—uterine cancer	0.00202	0.0263	CbGeAlD
Liotrix—SLCO1C1—renal system—uterine cancer	0.00192	0.0249	CbGeAlD
Liotrix—SLC16A2—uterus—uterine cancer	0.00186	0.0242	CbGeAlD
Liotrix—THRB—female reproductive system—uterine cancer	0.00185	0.024	CbGeAlD
Liotrix—THRA—female reproductive system—uterine cancer	0.00185	0.024	CbGeAlD
Liotrix—SLCO4C1—vagina—uterine cancer	0.00174	0.0226	CbGeAlD
Liotrix—TTR—renal system—uterine cancer	0.00172	0.0223	CbGeAlD
Liotrix—SLCO1B3—vagina—uterine cancer	0.0017	0.022	CbGeAlD
Liotrix—THRB—female gonad—uterine cancer	0.00168	0.0218	CbGeAlD
Liotrix—THRA—female gonad—uterine cancer	0.00168	0.0218	CbGeAlD
Liotrix—THRB—vagina—uterine cancer	0.00167	0.0217	CbGeAlD
Liotrix—SLC10A1—female reproductive system—uterine cancer	0.00164	0.0212	CbGeAlD
Liotrix—SLCO4A1—decidua—uterine cancer	0.00157	0.0203	CbGeAlD
Liotrix—SLCO4A1—renal system—uterine cancer	0.00154	0.02	CbGeAlD
Liotrix—SLC16A2—female gonad—uterine cancer	0.00152	0.0198	CbGeAlD
Liotrix—SLC16A2—vagina—uterine cancer	0.00152	0.0197	CbGeAlD
Liotrix—SLCO4A1—endometrium—uterine cancer	0.00149	0.0193	CbGeAlD
Liotrix—SLC16A10—epithelium—uterine cancer	0.00145	0.0189	CbGeAlD
Liotrix—SLCO4A1—mammalian vulva—uterine cancer	0.00144	0.0187	CbGeAlD
Liotrix—TTR—female reproductive system—uterine cancer	0.00137	0.0178	CbGeAlD
Liotrix—SLCO1B1—renal system—uterine cancer	0.00135	0.0176	CbGeAlD
Liotrix—SLC16A10—mammalian vulva—uterine cancer	0.00126	0.0164	CbGeAlD
Liotrix—SLCO4A1—female reproductive system—uterine cancer	0.00123	0.016	CbGeAlD
Liotrix—SLCO4A1—vagina—uterine cancer	0.00111	0.0145	CbGeAlD
Liotrix—SLCO1A2—renal system—uterine cancer	0.0011	0.0143	CbGeAlD
Liotrix—SLCO1B1—female reproductive system—uterine cancer	0.00108	0.0141	CbGeAlD
Liotrix—THRB—lymph node—uterine cancer	0.00108	0.014	CbGeAlD
Liotrix—THRA—lymph node—uterine cancer	0.00108	0.014	CbGeAlD
Liotrix—SLC16A10—female reproductive system—uterine cancer	0.00108	0.014	CbGeAlD
Liotrix—SLC22A8—renal system—uterine cancer	0.00105	0.0137	CbGeAlD
Liotrix—SLC16A2—lymph node—uterine cancer	0.00098	0.0127	CbGeAlD
Liotrix—SLC16A10—vagina—uterine cancer	0.000977	0.0127	CbGeAlD
Liotrix—SLCO1C1—lymph node—uterine cancer	0.000899	0.0117	CbGeAlD
Liotrix—CYP2C8—renal system—uterine cancer	0.00077	0.00999	CbGeAlD
Liotrix—CYP2C8—endometrium—uterine cancer	0.000744	0.00966	CbGeAlD
Liotrix—SLCO4A1—lymph node—uterine cancer	0.000721	0.00936	CbGeAlD
Liotrix—SLC16A10—lymph node—uterine cancer	0.000632	0.0082	CbGeAlD
Liotrix—CYP2C8—female reproductive system—uterine cancer	0.000616	0.008	CbGeAlD
Liotrix—CYP2C8—vagina—uterine cancer	0.000557	0.00724	CbGeAlD
Liotrix—ALB—lymph node—uterine cancer	0.000513	0.00666	CbGeAlD
Liotrix—ABCB1—myometrium—uterine cancer	0.000507	0.00658	CbGeAlD
Liotrix—Extravasation—Doxorubicin—uterine cancer	0.000399	0.00176	CcSEcCtD
Liotrix—ABCB1—epithelium—uterine cancer	0.000398	0.00516	CbGeAlD
Liotrix—Ulcer—Epirubicin—uterine cancer	0.000398	0.00176	CcSEcCtD
Liotrix—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000396	0.00175	CcSEcCtD
Liotrix—Creatinine increased—Epirubicin—uterine cancer	0.000395	0.00175	CcSEcCtD
Liotrix—ABCB1—uterine cervix—uterine cancer	0.000394	0.00512	CbGeAlD
Liotrix—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000386	0.00171	CcSEcCtD
Liotrix—Feeling abnormal—Progesterone—uterine cancer	0.000386	0.00171	CcSEcCtD
Liotrix—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000384	0.0017	CcSEcCtD
Liotrix—Cellulitis—Doxorubicin—uterine cancer	0.000383	0.00169	CcSEcCtD
Liotrix—Gastrointestinal pain—Progesterone—uterine cancer	0.000383	0.00169	CcSEcCtD
Liotrix—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000381	0.00168	CcSEcCtD
Liotrix—Hypocalcaemia—Doxorubicin—uterine cancer	0.00038	0.00168	CcSEcCtD
Liotrix—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000378	0.00167	CcSEcCtD
Liotrix—Oliguria—Doxorubicin—uterine cancer	0.000378	0.00167	CcSEcCtD
Liotrix—ABCB1—decidua—uterine cancer	0.000376	0.00488	CbGeAlD
Liotrix—Urticaria—Progesterone—uterine cancer	0.000372	0.00164	CcSEcCtD
Liotrix—Acute coronary syndrome—Etoposide—uterine cancer	0.00037	0.00164	CcSEcCtD
Liotrix—Abdominal pain—Progesterone—uterine cancer	0.00037	0.00164	CcSEcCtD
Liotrix—Body temperature increased—Progesterone—uterine cancer	0.00037	0.00164	CcSEcCtD
Liotrix—Renal failure—Etoposide—uterine cancer	0.000369	0.00163	CcSEcCtD
Liotrix—ABCB1—renal system—uterine cancer	0.000369	0.00479	CbGeAlD
Liotrix—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000369	0.00163	CcSEcCtD
Liotrix—Ulcer—Doxorubicin—uterine cancer	0.000368	0.00163	CcSEcCtD
Liotrix—Myocardial infarction—Etoposide—uterine cancer	0.000368	0.00163	CcSEcCtD
Liotrix—Creatinine increased—Doxorubicin—uterine cancer	0.000366	0.00162	CcSEcCtD
Liotrix—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000366	0.00162	CcSEcCtD
Liotrix—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000363	0.0016	CcSEcCtD
Liotrix—Fluid retention—Epirubicin—uterine cancer	0.000357	0.00158	CcSEcCtD
Liotrix—ABCB1—endometrium—uterine cancer	0.000357	0.00463	CbGeAlD
Liotrix—Blood urea increased—Epirubicin—uterine cancer	0.000355	0.00157	CcSEcCtD
Liotrix—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00035	0.00155	CcSEcCtD
Liotrix—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000347	0.00153	CcSEcCtD
Liotrix—ABCB1—mammalian vulva—uterine cancer	0.000345	0.00448	CbGeAlD
Liotrix—Hypersensitivity—Progesterone—uterine cancer	0.000345	0.00152	CcSEcCtD
Liotrix—Coma—Epirubicin—uterine cancer	0.000344	0.00152	CcSEcCtD
Liotrix—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000337	0.00149	CcSEcCtD
Liotrix—Asthenia—Progesterone—uterine cancer	0.000336	0.00148	CcSEcCtD
Liotrix—Hypoaesthesia—Etoposide—uterine cancer	0.000335	0.00148	CcSEcCtD
Liotrix—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000335	0.00148	CcSEcCtD
Liotrix—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000335	0.00148	CcSEcCtD
Liotrix—Pruritus—Progesterone—uterine cancer	0.000331	0.00146	CcSEcCtD
Liotrix—Oedema—Dactinomycin—uterine cancer	0.000331	0.00146	CcSEcCtD
Liotrix—Fluid retention—Doxorubicin—uterine cancer	0.000331	0.00146	CcSEcCtD
Liotrix—ABCB1—uterus—uterine cancer	0.000329	0.00427	CbGeAlD
Liotrix—Infection—Dactinomycin—uterine cancer	0.000329	0.00145	CcSEcCtD
Liotrix—Blood urea increased—Doxorubicin—uterine cancer	0.000329	0.00145	CcSEcCtD
Liotrix—Sepsis—Epirubicin—uterine cancer	0.000327	0.00144	CcSEcCtD
Liotrix—Diarrhoea—Progesterone—uterine cancer	0.00032	0.00142	CcSEcCtD
Liotrix—Coma—Doxorubicin—uterine cancer	0.000318	0.00141	CcSEcCtD
Liotrix—Phlebitis—Epirubicin—uterine cancer	0.000317	0.0014	CcSEcCtD
Liotrix—Anorexia—Dactinomycin—uterine cancer	0.000315	0.00139	CcSEcCtD
Liotrix—Flushing—Etoposide—uterine cancer	0.000313	0.00138	CcSEcCtD
Liotrix—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000313	0.00138	CcSEcCtD
Liotrix—Dizziness—Progesterone—uterine cancer	0.00031	0.00137	CcSEcCtD
Liotrix—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000304	0.00135	CcSEcCtD
Liotrix—Sepsis—Doxorubicin—uterine cancer	0.000302	0.00134	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000301	0.00133	CcSEcCtD
Liotrix—Cardiac failure congestive—Epirubicin—uterine cancer	0.000301	0.00133	CcSEcCtD
Liotrix—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.0003	0.00133	CcSEcCtD
Liotrix—Alopecia—Etoposide—uterine cancer	0.000298	0.00132	CcSEcCtD
Liotrix—Vomiting—Progesterone—uterine cancer	0.000298	0.00132	CcSEcCtD
Liotrix—Renal failure acute—Epirubicin—uterine cancer	0.000296	0.00131	CcSEcCtD
Liotrix—ABCB1—female reproductive system—uterine cancer	0.000296	0.00384	CbGeAlD
Liotrix—Rash—Progesterone—uterine cancer	0.000295	0.0013	CcSEcCtD
Liotrix—Dermatitis—Progesterone—uterine cancer	0.000295	0.0013	CcSEcCtD
Liotrix—Phlebitis—Doxorubicin—uterine cancer	0.000293	0.0013	CcSEcCtD
Liotrix—Headache—Progesterone—uterine cancer	0.000293	0.0013	CcSEcCtD
Liotrix—Increased appetite—Epirubicin—uterine cancer	0.000291	0.00128	CcSEcCtD
Liotrix—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00029	0.00128	CcSEcCtD
Liotrix—Decreased appetite—Dactinomycin—uterine cancer	0.000288	0.00127	CcSEcCtD
Liotrix—Dysgeusia—Etoposide—uterine cancer	0.000287	0.00127	CcSEcCtD
Liotrix—Renal impairment—Epirubicin—uterine cancer	0.000287	0.00127	CcSEcCtD
Liotrix—Fatigue—Dactinomycin—uterine cancer	0.000285	0.00126	CcSEcCtD
Liotrix—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000281	0.00124	CcSEcCtD
Liotrix—Cardiac failure—Epirubicin—uterine cancer	0.00028	0.00124	CcSEcCtD
Liotrix—Hypoglycaemia—Epirubicin—uterine cancer	0.00028	0.00124	CcSEcCtD
Liotrix—Cerebrovascular accident—Epirubicin—uterine cancer	0.000279	0.00123	CcSEcCtD
Liotrix—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000279	0.00123	CcSEcCtD
Liotrix—Nausea—Progesterone—uterine cancer	0.000278	0.00123	CcSEcCtD
Liotrix—Renal failure acute—Doxorubicin—uterine cancer	0.000274	0.00121	CcSEcCtD
Liotrix—Feeling abnormal—Dactinomycin—uterine cancer	0.000273	0.00121	CcSEcCtD
Liotrix—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000271	0.0012	CcSEcCtD
Liotrix—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00027	0.00119	CcSEcCtD
Liotrix—Increased appetite—Doxorubicin—uterine cancer	0.000269	0.00119	CcSEcCtD
Liotrix—ABCB1—female gonad—uterine cancer	0.000269	0.00349	CbGeAlD
Liotrix—Affect lability—Epirubicin—uterine cancer	0.000269	0.00119	CcSEcCtD
Liotrix—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000267	0.00118	CcSEcCtD
Liotrix—ABCB1—vagina—uterine cancer	0.000267	0.00347	CbGeAlD
Liotrix—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000267	0.00118	CcSEcCtD
Liotrix—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000266	0.00117	CcSEcCtD
Liotrix—Renal impairment—Doxorubicin—uterine cancer	0.000266	0.00117	CcSEcCtD
Liotrix—Abdominal pain—Dactinomycin—uterine cancer	0.000262	0.00116	CcSEcCtD
Liotrix—Body temperature increased—Dactinomycin—uterine cancer	0.000262	0.00116	CcSEcCtD
Liotrix—Cardiac arrest—Epirubicin—uterine cancer	0.00026	0.00115	CcSEcCtD
Liotrix—Cardiac failure—Doxorubicin—uterine cancer	0.000259	0.00114	CcSEcCtD
Liotrix—Hypoglycaemia—Doxorubicin—uterine cancer	0.000259	0.00114	CcSEcCtD
Liotrix—Mood swings—Epirubicin—uterine cancer	0.000259	0.00114	CcSEcCtD
Liotrix—Loss of consciousness—Etoposide—uterine cancer	0.000258	0.00114	CcSEcCtD
Liotrix—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000258	0.00114	CcSEcCtD
Liotrix—Blood creatinine increased—Epirubicin—uterine cancer	0.000256	0.00113	CcSEcCtD
Liotrix—Convulsion—Etoposide—uterine cancer	0.000254	0.00112	CcSEcCtD
Liotrix—Dehydration—Epirubicin—uterine cancer	0.000254	0.00112	CcSEcCtD
Liotrix—Hypertension—Etoposide—uterine cancer	0.000253	0.00112	CcSEcCtD
Liotrix—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000252	0.00111	CcSEcCtD
Liotrix—Chest pain—Etoposide—uterine cancer	0.00025	0.0011	CcSEcCtD
Liotrix—Affect lability—Doxorubicin—uterine cancer	0.000249	0.0011	CcSEcCtD
Liotrix—Hypokalaemia—Epirubicin—uterine cancer	0.000249	0.0011	CcSEcCtD
Liotrix—Hypersensitivity—Dactinomycin—uterine cancer	0.000244	0.00108	CcSEcCtD
Liotrix—Confusional state—Etoposide—uterine cancer	0.000241	0.00107	CcSEcCtD
Liotrix—Muscular weakness—Epirubicin—uterine cancer	0.000241	0.00106	CcSEcCtD
Liotrix—Cardiac arrest—Doxorubicin—uterine cancer	0.00024	0.00106	CcSEcCtD
Liotrix—Anaphylactic shock—Etoposide—uterine cancer	0.000239	0.00106	CcSEcCtD
Liotrix—Mood swings—Doxorubicin—uterine cancer	0.000239	0.00106	CcSEcCtD
Liotrix—Infection—Etoposide—uterine cancer	0.000238	0.00105	CcSEcCtD
Liotrix—Abdominal distension—Epirubicin—uterine cancer	0.000238	0.00105	CcSEcCtD
Liotrix—Asthenia—Dactinomycin—uterine cancer	0.000237	0.00105	CcSEcCtD
Liotrix—Blood creatinine increased—Doxorubicin—uterine cancer	0.000237	0.00105	CcSEcCtD
Liotrix—Dysphagia—Epirubicin—uterine cancer	0.000236	0.00104	CcSEcCtD
Liotrix—Dehydration—Doxorubicin—uterine cancer	0.000235	0.00104	CcSEcCtD
Liotrix—Tachycardia—Etoposide—uterine cancer	0.000234	0.00103	CcSEcCtD
Liotrix—Hyperhidrosis—Etoposide—uterine cancer	0.000232	0.00102	CcSEcCtD
Liotrix—Hypokalaemia—Doxorubicin—uterine cancer	0.00023	0.00102	CcSEcCtD
Liotrix—Angina pectoris—Epirubicin—uterine cancer	0.00023	0.00102	CcSEcCtD
Liotrix—Anorexia—Etoposide—uterine cancer	0.000228	0.00101	CcSEcCtD
Liotrix—Bronchitis—Epirubicin—uterine cancer	0.000227	0.001	CcSEcCtD
Liotrix—Diarrhoea—Dactinomycin—uterine cancer	0.000226	0.001	CcSEcCtD
Liotrix—Hypotension—Etoposide—uterine cancer	0.000224	0.000989	CcSEcCtD
Liotrix—Muscular weakness—Doxorubicin—uterine cancer	0.000223	0.000985	CcSEcCtD
Liotrix—Abdominal distension—Doxorubicin—uterine cancer	0.00022	0.000972	CcSEcCtD
Liotrix—Dysphagia—Doxorubicin—uterine cancer	0.000218	0.000965	CcSEcCtD
Liotrix—Paraesthesia—Etoposide—uterine cancer	0.000215	0.00095	CcSEcCtD
Liotrix—Weight decreased—Epirubicin—uterine cancer	0.000214	0.000944	CcSEcCtD
Liotrix—Dyspnoea—Etoposide—uterine cancer	0.000214	0.000944	CcSEcCtD
Liotrix—Angina pectoris—Doxorubicin—uterine cancer	0.000213	0.00094	CcSEcCtD
Liotrix—Vomiting—Dactinomycin—uterine cancer	0.00021	0.00093	CcSEcCtD
Liotrix—Bronchitis—Doxorubicin—uterine cancer	0.00021	0.000928	CcSEcCtD
Liotrix—Rash—Dactinomycin—uterine cancer	0.000209	0.000922	CcSEcCtD
Liotrix—Decreased appetite—Etoposide—uterine cancer	0.000208	0.00092	CcSEcCtD
Liotrix—Renal failure—Epirubicin—uterine cancer	0.000207	0.000914	CcSEcCtD
Liotrix—Fatigue—Etoposide—uterine cancer	0.000206	0.000913	CcSEcCtD
Liotrix—Constipation—Etoposide—uterine cancer	0.000205	0.000905	CcSEcCtD
Liotrix—Sweating—Epirubicin—uterine cancer	0.000202	0.000892	CcSEcCtD
Liotrix—Weight decreased—Doxorubicin—uterine cancer	0.000198	0.000873	CcSEcCtD
Liotrix—Feeling abnormal—Etoposide—uterine cancer	0.000197	0.000872	CcSEcCtD
Liotrix—Nausea—Dactinomycin—uterine cancer	0.000197	0.000869	CcSEcCtD
Liotrix—Gastrointestinal pain—Etoposide—uterine cancer	0.000196	0.000866	CcSEcCtD
Liotrix—Renal failure—Doxorubicin—uterine cancer	0.000191	0.000846	CcSEcCtD
Liotrix—Urticaria—Etoposide—uterine cancer	0.00019	0.000841	CcSEcCtD
Liotrix—Abdominal pain—Etoposide—uterine cancer	0.000189	0.000837	CcSEcCtD
Liotrix—Body temperature increased—Etoposide—uterine cancer	0.000189	0.000837	CcSEcCtD
Liotrix—Hypoaesthesia—Epirubicin—uterine cancer	0.000188	0.000831	CcSEcCtD
Liotrix—Sweating—Doxorubicin—uterine cancer	0.000187	0.000825	CcSEcCtD
Liotrix—Hypersensitivity—Etoposide—uterine cancer	0.000176	0.00078	CcSEcCtD
Liotrix—Flushing—Epirubicin—uterine cancer	0.000175	0.000775	CcSEcCtD
Liotrix—Hypoaesthesia—Doxorubicin—uterine cancer	0.000174	0.000769	CcSEcCtD
Liotrix—ABCB1—lymph node—uterine cancer	0.000173	0.00224	CbGeAlD
Liotrix—Asthenia—Etoposide—uterine cancer	0.000172	0.000759	CcSEcCtD
Liotrix—Pruritus—Etoposide—uterine cancer	0.000169	0.000749	CcSEcCtD
Liotrix—Arrhythmia—Epirubicin—uterine cancer	0.000169	0.000746	CcSEcCtD
Liotrix—Alopecia—Epirubicin—uterine cancer	0.000167	0.000738	CcSEcCtD
Liotrix—Diarrhoea—Etoposide—uterine cancer	0.000164	0.000724	CcSEcCtD
Liotrix—Flushing—Doxorubicin—uterine cancer	0.000162	0.000717	CcSEcCtD
Liotrix—Flatulence—Epirubicin—uterine cancer	0.000162	0.000716	CcSEcCtD
Liotrix—Tension—Epirubicin—uterine cancer	0.000161	0.000713	CcSEcCtD
Liotrix—Dysgeusia—Epirubicin—uterine cancer	0.000161	0.000712	CcSEcCtD
Liotrix—Nervousness—Epirubicin—uterine cancer	0.00016	0.000706	CcSEcCtD
Liotrix—Dizziness—Etoposide—uterine cancer	0.000158	0.0007	CcSEcCtD
Liotrix—Arrhythmia—Doxorubicin—uterine cancer	0.000156	0.00069	CcSEcCtD
Liotrix—Vision blurred—Epirubicin—uterine cancer	0.000155	0.000685	CcSEcCtD
Liotrix—Alopecia—Doxorubicin—uterine cancer	0.000154	0.000683	CcSEcCtD
Liotrix—Vomiting—Etoposide—uterine cancer	0.000152	0.000673	CcSEcCtD
Liotrix—Agitation—Epirubicin—uterine cancer	0.000151	0.000668	CcSEcCtD
Liotrix—Rash—Etoposide—uterine cancer	0.000151	0.000667	CcSEcCtD
Liotrix—Dermatitis—Etoposide—uterine cancer	0.000151	0.000667	CcSEcCtD
Liotrix—Headache—Etoposide—uterine cancer	0.00015	0.000663	CcSEcCtD
Liotrix—Flatulence—Doxorubicin—uterine cancer	0.00015	0.000663	CcSEcCtD
Liotrix—Tension—Doxorubicin—uterine cancer	0.000149	0.00066	CcSEcCtD
Liotrix—Dysgeusia—Doxorubicin—uterine cancer	0.000149	0.000659	CcSEcCtD
Liotrix—Nervousness—Doxorubicin—uterine cancer	0.000148	0.000653	CcSEcCtD
Liotrix—Syncope—Epirubicin—uterine cancer	0.000148	0.000652	CcSEcCtD
Liotrix—Palpitations—Epirubicin—uterine cancer	0.000145	0.000642	CcSEcCtD
Liotrix—Loss of consciousness—Epirubicin—uterine cancer	0.000145	0.000639	CcSEcCtD
Liotrix—Vision blurred—Doxorubicin—uterine cancer	0.000143	0.000634	CcSEcCtD
Liotrix—Convulsion—Epirubicin—uterine cancer	0.000143	0.00063	CcSEcCtD
Liotrix—Nausea—Etoposide—uterine cancer	0.000142	0.000629	CcSEcCtD
Liotrix—Hypertension—Epirubicin—uterine cancer	0.000142	0.000628	CcSEcCtD
Liotrix—Arthralgia—Epirubicin—uterine cancer	0.00014	0.000619	CcSEcCtD
Liotrix—Chest pain—Epirubicin—uterine cancer	0.00014	0.000619	CcSEcCtD
Liotrix—Agitation—Doxorubicin—uterine cancer	0.00014	0.000618	CcSEcCtD
Liotrix—Anxiety—Epirubicin—uterine cancer	0.00014	0.000617	CcSEcCtD
Liotrix—Syncope—Doxorubicin—uterine cancer	0.000136	0.000603	CcSEcCtD
Liotrix—Confusional state—Epirubicin—uterine cancer	0.000135	0.000598	CcSEcCtD
Liotrix—Palpitations—Doxorubicin—uterine cancer	0.000134	0.000594	CcSEcCtD
Liotrix—Anaphylactic shock—Epirubicin—uterine cancer	0.000134	0.000593	CcSEcCtD
Liotrix—Oedema—Epirubicin—uterine cancer	0.000134	0.000593	CcSEcCtD
Liotrix—Loss of consciousness—Doxorubicin—uterine cancer	0.000134	0.000591	CcSEcCtD
Liotrix—Infection—Epirubicin—uterine cancer	0.000133	0.000589	CcSEcCtD
Liotrix—Shock—Epirubicin—uterine cancer	0.000132	0.000584	CcSEcCtD
Liotrix—Convulsion—Doxorubicin—uterine cancer	0.000132	0.000583	CcSEcCtD
Liotrix—Hypertension—Doxorubicin—uterine cancer	0.000131	0.000581	CcSEcCtD
Liotrix—Tachycardia—Epirubicin—uterine cancer	0.000131	0.000579	CcSEcCtD
Liotrix—Hyperhidrosis—Epirubicin—uterine cancer	0.00013	0.000574	CcSEcCtD
Liotrix—Chest pain—Doxorubicin—uterine cancer	0.00013	0.000573	CcSEcCtD
Liotrix—Arthralgia—Doxorubicin—uterine cancer	0.00013	0.000573	CcSEcCtD
Liotrix—Anxiety—Doxorubicin—uterine cancer	0.000129	0.000571	CcSEcCtD
Liotrix—Anorexia—Epirubicin—uterine cancer	0.000128	0.000566	CcSEcCtD
Liotrix—Hypotension—Epirubicin—uterine cancer	0.000125	0.000554	CcSEcCtD
Liotrix—Confusional state—Doxorubicin—uterine cancer	0.000125	0.000554	CcSEcCtD
Liotrix—Anaphylactic shock—Doxorubicin—uterine cancer	0.000124	0.000549	CcSEcCtD
Liotrix—Oedema—Doxorubicin—uterine cancer	0.000124	0.000549	CcSEcCtD
Liotrix—Infection—Doxorubicin—uterine cancer	0.000123	0.000545	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000122	0.000541	CcSEcCtD
Liotrix—Shock—Doxorubicin—uterine cancer	0.000122	0.00054	CcSEcCtD
Liotrix—Insomnia—Epirubicin—uterine cancer	0.000121	0.000537	CcSEcCtD
Liotrix—Tachycardia—Doxorubicin—uterine cancer	0.000121	0.000536	CcSEcCtD
Liotrix—Paraesthesia—Epirubicin—uterine cancer	0.000121	0.000533	CcSEcCtD
Liotrix—Hyperhidrosis—Doxorubicin—uterine cancer	0.00012	0.000531	CcSEcCtD
Liotrix—Dyspnoea—Epirubicin—uterine cancer	0.00012	0.000529	CcSEcCtD
Liotrix—Anorexia—Doxorubicin—uterine cancer	0.000118	0.000523	CcSEcCtD
Liotrix—Decreased appetite—Epirubicin—uterine cancer	0.000117	0.000516	CcSEcCtD
Liotrix—Hypotension—Doxorubicin—uterine cancer	0.000116	0.000513	CcSEcCtD
Liotrix—Fatigue—Epirubicin—uterine cancer	0.000116	0.000512	CcSEcCtD
Liotrix—Constipation—Epirubicin—uterine cancer	0.000115	0.000507	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000113	0.0005	CcSEcCtD
Liotrix—Insomnia—Doxorubicin—uterine cancer	0.000112	0.000497	CcSEcCtD
Liotrix—Paraesthesia—Doxorubicin—uterine cancer	0.000112	0.000493	CcSEcCtD
Liotrix—Dyspnoea—Doxorubicin—uterine cancer	0.000111	0.000489	CcSEcCtD
Liotrix—Feeling abnormal—Epirubicin—uterine cancer	0.000111	0.000489	CcSEcCtD
Liotrix—Gastrointestinal pain—Epirubicin—uterine cancer	0.00011	0.000485	CcSEcCtD
Liotrix—Decreased appetite—Doxorubicin—uterine cancer	0.000108	0.000477	CcSEcCtD
Liotrix—Fatigue—Doxorubicin—uterine cancer	0.000107	0.000473	CcSEcCtD
Liotrix—Urticaria—Epirubicin—uterine cancer	0.000107	0.000471	CcSEcCtD
Liotrix—Constipation—Doxorubicin—uterine cancer	0.000106	0.000469	CcSEcCtD
Liotrix—Abdominal pain—Epirubicin—uterine cancer	0.000106	0.000469	CcSEcCtD
Liotrix—Body temperature increased—Epirubicin—uterine cancer	0.000106	0.000469	CcSEcCtD
Liotrix—Feeling abnormal—Doxorubicin—uterine cancer	0.000102	0.000452	CcSEcCtD
Liotrix—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000102	0.000449	CcSEcCtD
Liotrix—Hypersensitivity—Epirubicin—uterine cancer	9.89e-05	0.000437	CcSEcCtD
Liotrix—Urticaria—Doxorubicin—uterine cancer	9.87e-05	0.000436	CcSEcCtD
Liotrix—Abdominal pain—Doxorubicin—uterine cancer	9.82e-05	0.000434	CcSEcCtD
Liotrix—Body temperature increased—Doxorubicin—uterine cancer	9.82e-05	0.000434	CcSEcCtD
Liotrix—Asthenia—Epirubicin—uterine cancer	9.63e-05	0.000426	CcSEcCtD
Liotrix—Pruritus—Epirubicin—uterine cancer	9.5e-05	0.00042	CcSEcCtD
Liotrix—Diarrhoea—Epirubicin—uterine cancer	9.18e-05	0.000406	CcSEcCtD
Liotrix—Hypersensitivity—Doxorubicin—uterine cancer	9.15e-05	0.000404	CcSEcCtD
Liotrix—Asthenia—Doxorubicin—uterine cancer	8.91e-05	0.000394	CcSEcCtD
Liotrix—Dizziness—Epirubicin—uterine cancer	8.88e-05	0.000392	CcSEcCtD
Liotrix—Pruritus—Doxorubicin—uterine cancer	8.79e-05	0.000388	CcSEcCtD
Liotrix—Vomiting—Epirubicin—uterine cancer	8.54e-05	0.000377	CcSEcCtD
Liotrix—Diarrhoea—Doxorubicin—uterine cancer	8.5e-05	0.000376	CcSEcCtD
Liotrix—Rash—Epirubicin—uterine cancer	8.46e-05	0.000374	CcSEcCtD
Liotrix—Dermatitis—Epirubicin—uterine cancer	8.46e-05	0.000374	CcSEcCtD
Liotrix—Headache—Epirubicin—uterine cancer	8.41e-05	0.000372	CcSEcCtD
Liotrix—SLC10A1—Metabolism—POLD1—uterine cancer	8.26e-05	0.00148	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—CCL2—uterine cancer	8.24e-05	0.00148	CbGpPWpGaD
Liotrix—Dizziness—Doxorubicin—uterine cancer	8.21e-05	0.000363	CcSEcCtD
Liotrix—TTR—Disease—DCN—uterine cancer	8.07e-05	0.00145	CbGpPWpGaD
Liotrix—Nausea—Epirubicin—uterine cancer	7.97e-05	0.000352	CcSEcCtD
Liotrix—TTR—Signaling Pathways—RNF43—uterine cancer	7.93e-05	0.00143	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.9e-05	0.00142	CbGpPWpGaD
Liotrix—Vomiting—Doxorubicin—uterine cancer	7.9e-05	0.000349	CcSEcCtD
Liotrix—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.86e-05	0.00141	CbGpPWpGaD
Liotrix—Rash—Doxorubicin—uterine cancer	7.83e-05	0.000346	CcSEcCtD
Liotrix—Dermatitis—Doxorubicin—uterine cancer	7.82e-05	0.000346	CcSEcCtD
Liotrix—Headache—Doxorubicin—uterine cancer	7.78e-05	0.000344	CcSEcCtD
Liotrix—SLC10A1—Metabolism—AKR1C1—uterine cancer	7.72e-05	0.00139	CbGpPWpGaD
Liotrix—THRA—Gene Expression—CDKN2B—uterine cancer	7.58e-05	0.00136	CbGpPWpGaD
Liotrix—THRB—Gene Expression—CDKN2B—uterine cancer	7.58e-05	0.00136	CbGpPWpGaD
Liotrix—Nausea—Doxorubicin—uterine cancer	7.38e-05	0.000326	CcSEcCtD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	7.3e-05	0.00131	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—INHBA—uterine cancer	7.26e-05	0.0013	CbGpPWpGaD
Liotrix—TTR—Disease—AKR1C3—uterine cancer	7.18e-05	0.00129	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—SRD5A2—uterine cancer	7.16e-05	0.00129	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NDUFB11—uterine cancer	7.16e-05	0.00129	CbGpPWpGaD
Liotrix—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	7.07e-05	0.00127	CbGpPWpGaD
Liotrix—TTR—Disease—HMGA1—uterine cancer	7e-05	0.00126	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.96e-05	0.00125	CbGpPWpGaD
Liotrix—THRA—Gene Expression—SMAD3—uterine cancer	6.92e-05	0.00124	CbGpPWpGaD
Liotrix—THRB—Gene Expression—SMAD3—uterine cancer	6.92e-05	0.00124	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—RRM2—uterine cancer	6.88e-05	0.00124	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—DCN—uterine cancer	6.68e-05	0.0012	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKR1B1—uterine cancer	6.59e-05	0.00118	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—STAR—uterine cancer	6.59e-05	0.00118	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.57e-05	0.00118	CbGpPWpGaD
Liotrix—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	6.55e-05	0.00118	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	6.55e-05	0.00118	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKR1C1—uterine cancer	6.53e-05	0.00117	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.51e-05	0.00117	CbGpPWpGaD
Liotrix—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	6.46e-05	0.00116	CbGpPWpGaD
Liotrix—TTR—Disease—FBXW7—uterine cancer	6.4e-05	0.00115	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—CYP11A1—uterine cancer	6.3e-05	0.00113	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	6.23e-05	0.00112	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NDUFB11—uterine cancer	6.12e-05	0.0011	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—SRD5A2—uterine cancer	6.12e-05	0.0011	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.95e-05	0.00107	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AKR1C3—uterine cancer	5.95e-05	0.00107	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	5.78e-05	0.00104	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.71e-05	0.00103	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.71e-05	0.00103	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.68e-05	0.00102	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.68e-05	0.00102	CbGpPWpGaD
Liotrix—THRB—Gene Expression—ESR1—uterine cancer	5.65e-05	0.00102	CbGpPWpGaD
Liotrix—THRA—Gene Expression—ESR1—uterine cancer	5.65e-05	0.00102	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.62e-05	0.00101	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	5.4e-05	0.000971	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	5.25e-05	0.000943	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKR1B1—uterine cancer	5.18e-05	0.000931	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—STAR—uterine cancer	5.18e-05	0.000931	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—POLD1—uterine cancer	5.17e-05	0.00093	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.12e-05	0.00092	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKR1C3—uterine cancer	5.03e-05	0.000904	CbGpPWpGaD
Liotrix—TTR—Disease—CDKN2B—uterine cancer	5.02e-05	0.000901	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—CXCL8—uterine cancer	4.94e-05	0.000889	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PGR—uterine cancer	4.9e-05	0.000881	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	4.89e-05	0.00088	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKR1C1—uterine cancer	4.84e-05	0.000869	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	4.73e-05	0.000851	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	4.7e-05	0.000845	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—YWHAE—uterine cancer	4.68e-05	0.00084	CbGpPWpGaD
Liotrix—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	4.67e-05	0.000839	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	4.64e-05	0.000833	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—STK11—uterine cancer	4.63e-05	0.000833	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—CYP19A1—uterine cancer	4.63e-05	0.000833	CbGpPWpGaD
Liotrix—TTR—Disease—SMAD3—uterine cancer	4.58e-05	0.000823	CbGpPWpGaD
Liotrix—ALB—Platelet degranulation—VEGFA—uterine cancer	4.54e-05	0.000815	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—FBXW7—uterine cancer	4.48e-05	0.000806	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—STAR—uterine cancer	4.43e-05	0.000796	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKR1B1—uterine cancer	4.43e-05	0.000796	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.38e-05	0.000787	CbGpPWpGaD
Liotrix—TTR—Disease—FGFR2—uterine cancer	4.37e-05	0.000785	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.35e-05	0.000782	CbGpPWpGaD
Liotrix—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	4.32e-05	0.000777	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—RRM2—uterine cancer	4.31e-05	0.000775	CbGpPWpGaD
Liotrix—TTR—Disease—MTHFR—uterine cancer	4.2e-05	0.000756	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.19e-05	0.000754	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—DCN—uterine cancer	4.19e-05	0.000752	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.17e-05	0.000749	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.15e-05	0.000745	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—POLD1—uterine cancer	4.06e-05	0.00073	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—VEGFA—uterine cancer	4.01e-05	0.000722	CbGpPWpGaD
Liotrix—ALB—Folate Metabolism—TP53—uterine cancer	4e-05	0.000719	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CYP11A1—uterine cancer	3.94e-05	0.000709	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—STK11—uterine cancer	3.92e-05	0.000704	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKR1C1—uterine cancer	3.8e-05	0.000683	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKR1C3—uterine cancer	3.72e-05	0.000669	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SOCS3—uterine cancer	3.67e-05	0.000659	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SRD5A2—uterine cancer	3.52e-05	0.000633	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NDUFB11—uterine cancer	3.52e-05	0.000633	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CDKN2B—uterine cancer	3.51e-05	0.000631	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IRF1—uterine cancer	3.51e-05	0.00063	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	3.5e-05	0.00063	CbGpPWpGaD
Liotrix—ALB—Metabolism—NDUFB11—uterine cancer	3.5e-05	0.000629	CbGpPWpGaD
Liotrix—ALB—Metabolism—SRD5A2—uterine cancer	3.5e-05	0.000629	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—MTHFR—uterine cancer	3.48e-05	0.000626	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—POLD1—uterine cancer	3.47e-05	0.000625	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.42e-05	0.000614	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IGF1R—uterine cancer	3.41e-05	0.000613	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.4e-05	0.000611	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—RRM2—uterine cancer	3.39e-05	0.000609	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—DCN—uterine cancer	3.29e-05	0.000591	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKR1C1—uterine cancer	3.25e-05	0.000584	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.23e-05	0.00058	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.21e-05	0.000577	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SMAD3—uterine cancer	3.21e-05	0.000576	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CYP11A1—uterine cancer	3.1e-05	0.000557	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.07e-05	0.000551	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NDUFB11—uterine cancer	3.07e-05	0.000551	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SRD5A2—uterine cancer	3.07e-05	0.000551	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—FGFR2—uterine cancer	3.06e-05	0.00055	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.96e-05	0.000532	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKR1C3—uterine cancer	2.93e-05	0.000526	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—STK11—uterine cancer	2.9e-05	0.000521	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CYP19A1—uterine cancer	2.9e-05	0.000521	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—RRM2—uterine cancer	2.9e-05	0.000521	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—DCN—uterine cancer	2.81e-05	0.000505	CbGpPWpGaD
Liotrix—TTR—Disease—ERBB2—uterine cancer	2.74e-05	0.000493	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.72e-05	0.00049	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP11A1—uterine cancer	2.65e-05	0.000476	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ESR1—uterine cancer	2.62e-05	0.00047	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.6e-05	0.000467	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.57e-05	0.000462	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—STAR—uterine cancer	2.54e-05	0.000457	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.54e-05	0.000457	CbGpPWpGaD
Liotrix—TTR—Disease—CDKN1B—uterine cancer	2.54e-05	0.000457	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKR1B1—uterine cancer	2.53e-05	0.000455	CbGpPWpGaD
Liotrix—ALB—Metabolism—STAR—uterine cancer	2.53e-05	0.000455	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.52e-05	0.000452	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKR1C3—uterine cancer	2.5e-05	0.00045	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.5e-05	0.000449	CbGpPWpGaD
Liotrix—TTR—Disease—CTNNB1—uterine cancer	2.4e-05	0.000431	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.38e-05	0.000428	CbGpPWpGaD
Liotrix—TTR—Disease—PTEN—uterine cancer	2.34e-05	0.00042	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCL2—uterine cancer	2.3e-05	0.000414	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—STK11—uterine cancer	2.28e-05	0.00041	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CYP19A1—uterine cancer	2.28e-05	0.00041	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.25e-05	0.000405	CbGpPWpGaD
Liotrix—TTR—Disease—EP300—uterine cancer	2.23e-05	0.000401	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—STAR—uterine cancer	2.22e-05	0.000398	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKR1B1—uterine cancer	2.22e-05	0.000398	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.19e-05	0.000394	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—MTHFR—uterine cancer	2.18e-05	0.000392	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.14e-05	0.000385	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.09e-05	0.000376	CbGpPWpGaD
Liotrix—TTR—Disease—NRAS—uterine cancer	2.09e-05	0.000375	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.04e-05	0.000367	CbGpPWpGaD
Liotrix—THRA—Gene Expression—AKT1—uterine cancer	2.04e-05	0.000366	CbGpPWpGaD
Liotrix—THRB—Gene Expression—AKT1—uterine cancer	2.04e-05	0.000366	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	2.01e-05	0.000362	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—POLD1—uterine cancer	2e-05	0.000359	CbGpPWpGaD
Liotrix—ALB—Metabolism—POLD1—uterine cancer	1.99e-05	0.000357	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.98e-05	0.000356	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—STK11—uterine cancer	1.95e-05	0.00035	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP19A1—uterine cancer	1.95e-05	0.00035	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTEN—uterine cancer	1.94e-05	0.000348	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.92e-05	0.000345	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ERBB2—uterine cancer	1.92e-05	0.000345	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.87e-05	0.000336	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKR1C1—uterine cancer	1.86e-05	0.000334	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—EP300—uterine cancer	1.85e-05	0.000332	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.83e-05	0.000329	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CXCL8—uterine cancer	1.82e-05	0.000327	CbGpPWpGaD
Liotrix—TTR—Disease—KRAS—uterine cancer	1.8e-05	0.000323	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CDKN1B—uterine cancer	1.78e-05	0.00032	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.74e-05	0.000314	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—POLD1—uterine cancer	1.74e-05	0.000313	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—MTHFR—uterine cancer	1.71e-05	0.000308	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.68e-05	0.000303	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CTNNB1—uterine cancer	1.68e-05	0.000302	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—RRM2—uterine cancer	1.66e-05	0.000299	CbGpPWpGaD
Liotrix—ALB—Metabolism—RRM2—uterine cancer	1.66e-05	0.000297	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CA—uterine cancer	1.65e-05	0.000297	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PTEN—uterine cancer	1.64e-05	0.000294	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKR1C1—uterine cancer	1.63e-05	0.000292	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—DCN—uterine cancer	1.62e-05	0.00029	CbGpPWpGaD
Liotrix—ALB—Metabolism—DCN—uterine cancer	1.61e-05	0.000289	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.57e-05	0.000282	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EP300—uterine cancer	1.56e-05	0.000281	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.55e-05	0.000278	CbGpPWpGaD
Liotrix—TTR—Disease—HRAS—uterine cancer	1.53e-05	0.000274	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.52e-05	0.000274	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP11A1—uterine cancer	1.51e-05	0.000272	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.51e-05	0.000271	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.5e-05	0.000269	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—VEGFA—uterine cancer	1.48e-05	0.000266	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—MTHFR—uterine cancer	1.46e-05	0.000263	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NRAS—uterine cancer	1.46e-05	0.000263	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—RRM2—uterine cancer	1.45e-05	0.000261	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.44e-05	0.000258	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKR1C3—uterine cancer	1.43e-05	0.000257	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—DCN—uterine cancer	1.41e-05	0.000253	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CA—uterine cancer	1.37e-05	0.000246	CbGpPWpGaD
Liotrix—TTR—Disease—AKT1—uterine cancer	1.35e-05	0.000242	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP11A1—uterine cancer	1.33e-05	0.000238	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.29e-05	0.000232	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.28e-05	0.000231	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.26e-05	0.000227	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KRAS—uterine cancer	1.26e-05	0.000226	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKR1C3—uterine cancer	1.25e-05	0.000225	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTEN—uterine cancer	1.21e-05	0.000218	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—EP300—uterine cancer	1.16e-05	0.000208	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CA—uterine cancer	1.16e-05	0.000208	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—STK11—uterine cancer	1.12e-05	0.000201	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.12e-05	0.000201	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—uterine cancer	1.12e-05	0.000201	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AKT1—uterine cancer	1.12e-05	0.000201	CbGpPWpGaD
Liotrix—ALB—Metabolism—STK11—uterine cancer	1.11e-05	0.0002	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP19A1—uterine cancer	1.11e-05	0.0002	CbGpPWpGaD
Liotrix—ALB—Hemostasis—EP300—uterine cancer	1.1e-05	0.000197	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HRAS—uterine cancer	1.07e-05	0.000192	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.05e-05	0.000189	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.05e-05	0.000188	CbGpPWpGaD
Liotrix—ALB—Hemostasis—VEGFA—uterine cancer	1.04e-05	0.000186	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NRAS—uterine cancer	1.02e-05	0.000184	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1e-05	0.00018	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.97e-06	0.000179	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—STK11—uterine cancer	9.76e-06	0.000175	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP19A1—uterine cancer	9.76e-06	0.000175	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTEN—uterine cancer	9.53e-06	0.000171	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKT1—uterine cancer	9.44e-06	0.00017	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—EP300—uterine cancer	9.09e-06	0.000163	CbGpPWpGaD
Liotrix—ALB—Hemostasis—KRAS—uterine cancer	8.82e-06	0.000158	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CA—uterine cancer	8.56e-06	0.000154	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—MTHFR—uterine cancer	8.42e-06	0.000151	CbGpPWpGaD
Liotrix—ALB—Metabolism—MTHFR—uterine cancer	8.37e-06	0.00015	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTEN—uterine cancer	8.15e-06	0.000146	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CA—uterine cancer	8.1e-06	0.000146	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—uterine cancer	7.84e-06	0.000141	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—EP300—uterine cancer	7.77e-06	0.00014	CbGpPWpGaD
Liotrix—ALB—Hemostasis—HRAS—uterine cancer	7.5e-06	0.000135	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.42e-06	0.000133	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.38e-06	0.000133	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—MTHFR—uterine cancer	7.33e-06	0.000132	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKT1—uterine cancer	6.99e-06	0.000126	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CA—uterine cancer	6.72e-06	0.000121	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT1—uterine cancer	6.62e-06	0.000119	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CA—uterine cancer	5.75e-06	0.000103	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKT1—uterine cancer	5.49e-06	9.87e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKT1—uterine cancer	4.7e-06	8.44e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTEN—uterine cancer	4.68e-06	8.42e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTEN—uterine cancer	4.66e-06	8.37e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—EP300—uterine cancer	4.47e-06	8.03e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—EP300—uterine cancer	4.44e-06	7.98e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTEN—uterine cancer	4.08e-06	7.33e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—EP300—uterine cancer	3.89e-06	6.99e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.3e-06	5.94e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CA—uterine cancer	3.28e-06	5.9e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CA—uterine cancer	2.88e-06	5.17e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKT1—uterine cancer	2.7e-06	4.85e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKT1—uterine cancer	2.68e-06	4.82e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKT1—uterine cancer	2.35e-06	4.23e-05	CbGpPWpGaD
